Cummary
Acetanilide like phenylbutazone is paraoxidized by the liver endoplasmic reticulum as a primary biotransformation step. Both compounds were given at different times to each of 10 healthy volunteer subjects and the plasma disappearances measured. Correlation was shown between plasma clearance values of the two compounds (r = + 0 7067; P < 0-05).
Eight patients with hypoplastic anaemia after phenylbutazone therapy were investigated. Plasma clearance values and half lives of acetanilide were measured in this group of patients and compared with those of a group of 30 healthy volunteer controls. There was a significant decrease in clearance (P < 0.01) and lengthening of half lives (P < 0'001 in the patients with phenylbutazone-associated hypoplasia. Five patients with idiopathic aplastic anaemia-that is, without history of antecedent phenylbutazone ingestion-were similarly investigated with acetanilide and there was no significant difference between the results in these patients and those in the control group.
It is suggested that relatively poor paraoxidation of phenylbutazone producing high blood concentrations on a given dose may be a factor responsible for the drug-associated hypoplasia even though it does not explain the similar pattern of adverse reactions reported in association with oral administration of the metabolite oxyphenbutazone.
Introduction A wide interindividual variation in the ability to oxidize, and therefore to eliminate from the body, phenylbutazone has been shown in man (Bums et al., 1953; Whittaker and Evans, 1970) Metabolism of this compound is controlled by both polygenic and environmental factors, and in one family study the genetic contribution has been estimated to be about 66% (Whittaker and Evans, 1970) .
A serious complication of therapy with phenylbutazone is the appearance of bone marrow hypoplasia. Theoretically this could be due to accumulation of the parent compound or oxyphenbutazone, the major metabolite which is known to be toxic to bone marrow, or to the production of an unusual but toxic metmboilte. Other fatows involving man-ow responsiveness, the mechanisms of which are ill understood, could also operate.
This study was undertaken first to determine whether or not there was a correlation in a population of healthy subjects between oxidation rates of acetanilide and of phenylbutazone. Acetanilide was chosen as a particularly suitable compound for study because 84 % of it is oxidized to Nacetyl p-aminophenol (paracetamol), and the hepatic endoplasmic reticulum inserts one atom of oxygen in the para position of the benzene ring . Phenyl,butazone is also oxidized in the para position of its benzene ring but undergoes other less important biotransformations including oxidation on the aliphatic side chain (Bums et al., 1955) .
The second aim was to test the hypothesis that the marrow hypoplasia associated with phenylbutazone therapy might be due to accumulation of the parent compounds occurring in subjects who were relatively inefficient paraoxidizers and using acetanilide as a test drug. It was not possible to evaluate directly the role of phenylbutazone or its metabolites in patients with marrow hypoplasia, since it would have been unethical to re-expose patients to this drug.
Control Subjects
The 30 volunteer control subjects were healthy and drug free. None suffered from allergy or had had gastrointestinal surgery. There were 18 men and 12 women. All were under 30 years of age except for two who were aged 42 years. Most were senior university students. This group was not matched for age with the two groups of patients though it is clear from previous work that there is no significant correlation between age and rate of phenylbutazone metabolism in adult subjects (Whittaker and Evans, 1970; O'Malley et al., 1971 
Patients
Two groups of patients with aplastic anaemia were studied. The diagnostic criteria for aplastic anaemia were pancytopenia and hypoplasia of the bone marrow at some time during the course of the illness. Pancytopenia was defined as anaemia (Hb < 11.5 g/100 ml), neutropenia (neutrophils < 2,500/mm'), and thrombocytopenia (platelets < 150,000/ mm3) (Dacie and Lewis, 1968 
Methods

ACETANILIDE TEST
Before being admitted to the study all subjects gave their fully informed consent and were instructed not to take any drugs for two weeks previously except for specific steroid therapy being taken by the patient groups.
Participants were fasted ovemight for 12 hours before the test. The following morning a blank blood specimen was taken and they swallowed acetanilide in a dose of 50 mg/kg metabolically active mass (M.A.M. = weight to the power of 0 7; Drabkin, 1959) . A glass of water was taken with the acetanilide, and fasting continued for two hours. Thereafter, a low-fat light diet was allowed. Blood was withdrawn at five, seven, and nine hours after acetanilide ingestion, heparinized, centrifuged, and the plasma stored at -20'C to awai,t acetanilide analysis. Each subject's blank value was deducted from his other three values.
Previous work on the decline of acetanilide in plasma with respect to time has shown that three points provide a reasonable approximation to results obtained by obtaining samples at six time points.
Assay of acetanilide in plasma was achieved using modification of the method described by A similar calculation was used to obtain the apparent distribution volume of phenylbutazone though time 0 hours was taken to be the time the last 100-mg dose of phenylbutazone was taken. The total dose of phenylbutazone given to all subjects was 800 mg though by the time that the half life was measured, some of this would have been metabolized and excreted. In the calculation of apparent distribution volume the dose was therefore expressed as 100 units.
It Student's t test for unpaired data and correlation coefficient were used in the statistical analysis (Bailey, 1959 Clearance values for phenylbutazone in 10 of the 30 control subjects varied from 7-61 U to 12-84 U/hr. The mean (+ S.E.) was 10-7 + 0-67 U/hr. Correlation was shown between the clearance of phenylbutazone and acetanilide in these 10 subjects (r = + 0-7067; P < 0-05), fig. 2 The mean clearance value of acetanilide in patients with marrow hypoplasia unrelated to phenylbutazone ingestion was _ompared with the mean for the control group. The difference was not significant (table II; fig. 1 ).
The mean reduction in acetanilide clearance in patient.s with phenylbutazone-associated marrow hypoplasia was compared with the mean of the control group, and the difference was significant (P < 0 01; table II; fig. 1 ). The results of measuring acetanilide half lives are summarized in table II. Negative correlation was shown between the haemoglobin value at the time of the acetanilide test and the clearance of acetanilide in the eight patients with phenylbutazoneassociated marrow hypoplasia (r = -0 7213; P < 005). The mean haemoglobin level of the phenylbutazoneassociated group, however, was not significantly different from the mean haemoglobin in the non-phenylbutazoneassociated group (t = 08699; P > 005). In all 13 patients with marrow damage there was no relation between the haemoglobin and acetanilide clearance (r = -02067; P > 005).
There was no relation between the half lives of acetanilide and haemoglobin levels in the 13 subjects taken together (r = -02173; P > 0 05) nor between acetanilide half lives and haemoglobin levels in the eight subjects with phenylbutazone-associated marrow hypoplasia (r = 0-0638; P > 005). This work produces evidence to suggest that phenylbutazone accumulation due to delayed oxidation is a mechanism which may predispose to marrow damage, but there are difficulties in interpreting observations made on patients with varying degrees of illness. For instance, the patient in case 7 could be considered an atypical subject, having a long acetanilide half life and slow clearance. She was also mildly jaundiced (though a comparable subject in the nonphenylbutazone-associated hypoplastic group was also icteric). Omitting case 7 from the phenvlbutazone-associated hvpoplasia group, the mean haemoglobin levels of the two patient groups were still not significantly different (t = 0 9394; P > 0 05). Again omitting case 7, the mean clearance of acetanilide in the phenvlbutazone-associated group was still significantly reduced when compared with the 30 control sub;ects (t = -2-3921; P < 0-05).
Discussion
The effect of anaemia has been stated above, there being a negative correlation between haemoglobin and acetanilide clearance in the eight subjects with phenyvIbutazoneassociated hvpoplast'ic anaemia-that is, anaemiia had the effect of raising acetanilide clearance (presumably due mainly to increasing apparent distribution volume). The effect of increased blood flow (to all body organs including liver and kidney) in anaemia may also be relevant. This would militate against the result actually found so that there might be an even lower rate of clearance in subjects with phenylbutazone-associated hypoplasia than in controls. Similarly, when comparing the five non-phenylbutazone-induced subjects with controls despite some anaemic subjects in the former group the mean acetanilide clearances were very similar. Das et al. (1973) investigating adverse reactions during salicylazosulphapyridine therapy concluded that most of the toxic symptoms ascribed to this compound could be related to high serum concentrations of total sulphapyridine. Most subjects suffering side effects were slow acetylator phenotypes. One of their patients suffered from agranulocytosis and another from a reversible leucopenia, which did not reappear when salicylazosulphapyridine was reintroduced in a smaller dose. Both these patients had high serum levels of total sulphapyridine at the time of the discovery of the marrow injury. Yunis (1973) has recently reviewed the pathogenesis of bone marrow damage due to chloramphenicol. There is both clinical and experimental evidence that there are two distinct and unrelated types. Firstly, and much more commonly, there is a dose-related reversible inhibition of both mitochondrial protein synthesis and haem synthetase in red cell precursors. The depletion of haem synthetase is accompanied by a rise in free red cell protoporphyrins. In addition vacuolation of the marrow cells is observed by the light microscope and mitochondrial changes by the electron microscope. These effects are seen whenever chloramphenicol is given in sufficiently high doses, and all revert to normal within weeks of the drug being stopped.
Secondly, and much more rarely, there is the chloramphenicol-induced marrow aplasia which is unrelated to dove or duration of administration. This strongly suggests an individual predisposition. In-vitro marrow studies on these patients indicate that the effect is genetic and probably involves a single gene.
There may be two such mechanisms in the pathogenesis of phenylbutazone-induced marrow hvpoplasia. These results suggest, however, that drug accumulation is the major factor and it has been shown in the Manchester department (unpublished observation) that red cell protoporphyrins are raised in the same way as in ohlora¢nihenicol-induced aolasia due to excessive drug administation. The difference lies in the fact thait in phenylibutazone-induced aplasia the red cell protoporphyrins remain raised even after partial or avorrent comnlete remission. In one paieent the aplasia was followed by frank sideroblastic anaemia (Geary et al., 1974) .These facts suggest that the marrow damage is irreversible. (b) sharply cut-off vessels, (c) avascular opacities, (d) asymmetrical or asynchronous blood flow through arteries and veins (Simon and Sasahara, 1965) . Additional evidence was obtained from detection of increased pressures in the pulmonary arterial circulation, usually in the absence of raised "wedged" pressure (indirect left atrial pressure). In some patients remeasurement of pressures after an interval of days showed a fall or a return to normal values.
The collection and processing of blood for the N.B.T. test was carried out by the method previously described by Gordon et al. (1973) .
Whenever possible samples were processed immediately. When delay was unavoidable specimens were stored at 4'C (for a maximum of 12 hours) to prevent spontaneous enhancement of N.B.T. dye reduction (Winchester et al., 1973) . The criteria of neutrophil positivity were intracytoplasmic block deposits of formazan equalling or exceeding the size of individual neutrophil lobes (Segal et al., 1973; Gordon and Rowan, 1973 b) . Stippled cells were disregarded. Only intact neutrophils with clearly defined cell membranes were included in the count.
Results
The diagnosis of pulmonary thromboembolism was substantiated by angiography in 11 patients. In the three remaining patients the diagnosis was made on clinical and radiographical grounds. A satisfactory response to a continuous infusion of heparin occurred, however, in each patient in the absence of antibiotic therapy. Two patients with lobar pneumonia were subjected to angiography. No angiographic abnormality was found in either case. All patients with lobar pneumonia responded completely to antibiotic therapy.
One patient (case 14) with angiographically proven pulmonary embolism was in addition shown to be suffering from Mycoplasma pneumoniae infection (complement fixation titres obtained on paired sera: 1/256, 1/64).
